| Integrating genomic features for non-invasive early lung cancer detection JJ Chabon, EG Hamilton, DM Kurtz, MS Esfahani, EJ Moding, H Stehr, ... Nature 580 (7802), 245-251, 2020 | 454 | 2020 |
| Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA DM Kurtz, J Soo, L Co Ting Keh, S Alig, JJ Chabon, BJ Sworder, A Schultz, ... Nature biotechnology 39 (12), 1537-1547, 2021 | 177 | 2021 |
| Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer TD Azad, AA Chaudhuri, P Fang, Y Qiao, MS Esfahani, JJ Chabon, ... Gastroenterology 158 (3), 494-505. e6, 2020 | 171 | 2020 |
| Detection and surveillance of bladder cancer using urine tumor DNA JC Dudley, J Schroers-Martin, DV Lazzareschi, WY Shi, SB Chen, ... Cancer discovery 9 (4), 500-509, 2019 | 160 | 2019 |
| Inferring gene expression from cell-free DNA fragmentation profiles MS Esfahani, EG Hamilton, M Mehrmohamadi, BY Nabet, SK Alig, ... Nature biotechnology 40 (4), 585-597, 2022 | 76 | 2022 |
| Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas BJ Sworder, DM Kurtz, SK Alig, MJ Frank, N Shukla, A Garofalo, ... Cancer Cell 41 (1), 210-225. e5, 2023 | 51 | 2023 |
| CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity T Shree, V Shankar, JJK Lohmeyer, DK Czerwinski, JG Schroers-Martin, ... Blood cancer discovery 3 (2), 95-102, 2022 | 41 | 2022 |
| Determinants of circulating tumor DNA levels across lymphoma histologic subtypes JG Schroers-Martin, DM Kurtz, J Soo, M Jin, F Scherer, A Craig, ... Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 4018 …, 2017 | 16 | 2017 |
| Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors JG Schroers-Martin, J Soo, G Brisou, F Scherer, DM Kurtz, BJ Sworder, ... Cancer discovery 13 (6), 1310-1323, 2023 | 11 | 2023 |
| Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: an observational cohort study LM Yang, C Costales, M Ramanathan, PL Bulterys, K Murugesan, ... Journal of Clinical Virology 153, 105217, 2022 | 10 | 2022 |
| Circulating tumor DNA is a reliable measure of tumor burden at diagnosis of diffuse large B cell lymphoma: an international reproducibility study DM Kurtz, M Jin, J Soo, F Scherer, A Craig, JJ Chabon, ... Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 310-310, 2017 | 10 | 2017 |
| Distinct molecular subtypes of classic Hodgkin lymphoma identified by comprehensive noninvasive profiling SK Alig, M Shahrokh Esfahani, MY Li, RM Adams, A Garofalo, MC Jin, ... Blood 140 (Supplement 1), 1295-1296, 2022 | 6 | 2022 |
| Comparison of circulating tumor DNA recovery from plasma and serum J Soo, DM Kurtz, M Jin, F Scherer, JG Schroers-Martin, MS Esfahani, ... Blood 130, 2756, 2017 | 6 | 2017 |
| Distinct chromatin accessibility profiles of lymphoma subtypes revealed by targeted cell free dna profiling M Mehrmohamadi, MS Esfahani, J Soo, F Scherer, JG Schroers-Martin, ... Blood 132, 672, 2018 | 5 | 2018 |
| Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA. Cancer Discov. 2019; 9 (4): 500-9 JC Dudley, J Schroers-Martin, DV Lazzareschi, WY Shi, SB Chen, ... Epub 2018/12/24. https://doi. org/10.1158/2159-8290. CD-18-0825 PMID: 30578357, 0 | 5 | |
| Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling SK Alig, M Shahrokh Esfahani, A Garofalo, MY Li, C Rossi, T Flerlage, ... Nature 625 (7996), 778-787, 2024 | 4 | 2024 |
| Cell-mediated and humoral immune response to 2-dose SARS-CoV2 mRNA vaccination in immunocompromised patient population M Ramanathan, K Murugesan, LM Yang, C Costales, PL Bulterys, ... MedRxiv, 2021.07. 21.21260921, 2021 | 4 | 2021 |
| DETERMINANTS OF RESISTANCE TO ENGINEERED T‐CELL THERAPIES TARGETING CD19 IN LYMPHOMA B Sworder, DM Kurtz, S Alig, MJ Frank, CW Macauley, A Garofalo, ... Hematological Oncology 39, 2021 | 4 | 2021 |
| Noninvasive detection of clinically relevant copy number alterations in diffuse large B-cell lymphoma. MC Jin, DM Kurtz, MS Esfahani, F Scherer, AFM Craig, J Soo, ... Journal of Clinical Oncology 35 (15_suppl), 7507-7507, 2017 | 4 | 2017 |
| Circulating tumor DNA analysis for outcome prediction in localized esophageal cancer. TD Azad, A Chaudhuri, AM Newman, H Stehr, J Schroers-Martin, ... Journal of Clinical Oncology 35 (15_suppl), 4055-4055, 2017 | 4 | 2017 |
Ash A. Alizadeh, MD, PhDStanford University, Moghadam Family Professor of MedicineVerified email at stanford.edu
